Viral pathogens represent a significant public health threat; not only can viruses cause natural epidemics of human disease, but their potential use in bioterrorism is also a concern. A better understanding of the cellular factors that impact infection would facilitate the development of muchneeded therapeutics. Recent advances in RNA interference (RNAi) technology coupled with complete genome sequencing of several organisms has led to the optimization of genome-wide, cell-based loss-of-function screens. Drosophila cells are particularly amenable to genome-scale screens because of the ease and efficiency of RNAi in this system . Moreover, many of the cellular factors required for viral replication in Drosophila cell culture are also limiting in human cells infected with these viruses 4,6,7,8, 9 . Therefore, the identification of host factors co-opted during viral infection presents novel targets for antiviral therapeutics. Here we present a generalized protocol for a highthroughput RNAi screen to identify cellular factors involved in viral infection, using vaccinia virus as an example.
1
. Importantly, a wide variety of viruses can infect Drosophila cells, including a number of mammalian viruses of medical and agricultural importance 2, 3, 4 . Previous RNAi screens in Drosophila have identified host factors that are required for various steps in virus infection including entry, translation and RNA replication 5 . Moreover, many of the cellular factors required for viral replication in Drosophila cell culture are also limiting in human cells infected with these viruses 4, 6, 7, 8, 9 . Therefore, the identification of host factors co-opted during viral infection presents novel targets for antiviral therapeutics. Here we present a generalized protocol for a highthroughput RNAi screen to identify cellular factors involved in viral infection, using vaccinia virus as an example.
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Discussion
Genome-wide RNAi screening in Drosophila provides a robust and efficient method for examining the cellular component of viral infection. A number of mammalian viruses infect Drosophila cells, which can be used to identify components of the host intrinsic immune response, and host protein factors required for viral replication that may represent novel therapeutic targets. Before performing a screen, the assay must be carefully optimized for cell type, cell number, and infection level, and must be well controlled, including both positive and negative viral and cellular targets 11 . It is important to ensure sufficient separation between positive and negative controls prior to screening to maximize the dynamic range of the assay. Once the screen has been performed, candidates can be divided into functional categories to determine which host mechanisms contribute to infection. For mammalian viruses such as vaccinia, the contribution of mammalian homologs by RNAi should be determined as part of secondary analysis. Taken together, these robust screening methods will allow us to gain insight into complex mechanisms by which viruses interact with their host cells.
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